Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Once-daily DOAC for stroke prevention in AF and for clots. | Twice-daily blood thinner without routine monitoring. |
| Body system | Blood & Clotting | Blood & Clotting |
| Drug class | Direct oral anticoagulants | Direct oral anticoagulants |
| Supply | Prescription only | Prescription only |
| Main uses | Stroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism | Stroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacement |
| How it works | Thins the blood by blocking factor Xa. | Blocks one key clotting protein directly. |
| Starts working | 1–2 hours | 3–4 hours |
| Half-life | 10–14 hours | About 12 hours |
| Typical adult dose | 60 mg once a day; 30 mg once a day if kidney clearance 15–50 mL/min, weight 60 kg or less or certain interacting medicines. | AF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day. |
| Forms | Tablet | Tablet |
| Common side effects | Bleeding, Bruising, Anaemia, Nausea | Bruising, Nosebleeds, Heavy periods |
| Serious side effects | Major bleeding, Bleeding in the brain, Spinal haematoma | Major bleeding, Bleeding in the brain (less than with warfarin) |
| Don't take if | Active bleeding; Severe liver disease with coagulopathy; Uncontrolled severe high blood pressure; Mechanical heart valves | Active major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review |
| Alcohol | Best to limit. Heavy drinking raises bleeding risk. | Best to limit. Alcohol raises bleeding risk. |
| Pregnancy | Usually avoidedAvoid in pregnancy. | Usually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred. |
| Breastfeeding | Usually avoidedNot recommended. | Usually avoidedAvoid. |
| In use since | — | 2012 |
| Brand names | United States: SavaysaUnited Kingdom: LixianaIndia: Lixiana | United States: EliquisUnited Kingdom: EliquisIndia: Eliquis, Apigat |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | B01AF03 | B01AF02 |
Taken together
- MajorEdoxaban + Apixaban: Double anticoagulation — serious bleeding risk
Two blood thinners together greatly increase the risk of major bleeding.